HGH 191AA Dosage Protocol | PeptideDosages.com

HGH 191AA (10IU Vial) Dosage Protocol

HGH 191AA (3.33 mg Vial) Dosage Protocol

HGH 191AA Dosage Chart

HGH 191AA is dosed at 200 mcg–900 mcg daily via subcutaneous injection in educational protocols. A 10IU vial reconstituted with bacteriostatic water yields about 1.11 mg/mL. This information is for research and educational use only.

Reconstitute: Add 3.0 mL bacteriostatic water → ~1.11 mg/mL concentration (~1111 mcg/mL).

Typical daily range: 150–500 mcg (conservative replacement protocols)[1] to 1000–2000 mcg (advanced metabolic studies)[4].

Easy measuring: At 1.11 mg/mL, 1 unit = 0.01 mL ≈ 11.1 mcg on a U-100 insulin syringe.

Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

HGH 191AA is recombinant human growth hormone (somatropin) identical to endogenous GH, studied extensively for its effects on body composition, metabolism, and tissue repair[1][7]. Clinical protocols typically employ subcutaneous administration once daily to mimic physiological GH secretion patterns[2][3]. This educational protocol presents a gradual titration approach using practical dilution for precise insulin-syringe measurements.

Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read What is HGH 191AA? Evidence‑Based Guide for Peptide Beginners.

Standard / Gradual Titration (3 mL = ~1.11 mg/mL)

Week 1

200 mcg

18 units (0.18 mL)

Week 2

300 mcg

27 units (0.27 mL)

Week 3

400 mcg

36 units (0.36 mL)

Week 4

500 mcg

45 units (0.45 mL)

Week 5

600 mcg

54 units (0.54 mL)

Week 6

700 mcg

63 units (0.63 mL)

Week 7

800 mcg

72 units (0.72 mL)

Week 8

900 mcg

81 units (0.81 mL)

Frequency: Inject once daily subcutaneously, preferably at bedtime to mimic physiological GH secretion[2]. Rotate injection sites to prevent lipoatrophy[3]. This 8-week protocol represents a conservative approach with gradual dose escalation by approximately 100 mcg per week.

Extended 12-Week Protocol (Optional)

Week 9

1000 mcg

90 units (0.90 mL)

Week 10

1100 mcg

99 units (0.99 mL)

Week 11

1200 mcg

108 units (1.08 mL)

Week 12

1300 mcg

117 units (1.17 mL)

Note: The 12-week extension reaches higher daily doses (1000–1300 mcg) that have been explored in performance and metabolic research settings[4]. These doses yield more significant physiological effects but also increase the potential for side effects. Further extension to 16 weeks (reaching 1700 mcg daily) may be considered in advanced protocols, though such aggressive regimens should be undertaken with appropriate monitoring.

Reconstitution Steps

Draw 3.0 mL bacteriostatic water with a sterile syringe.

Inject slowly down the vial wall; avoid foaming.

Gently swirl/roll until dissolved (do not shake vigorously to preserve protein structure)[5].

Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Supplies Needed

Plan based on an 8–16 week daily protocol with gradual titration.

Peptide Vials (HGH 191AA, 10 IU / 3.33 mg each):

8 weeks ≈ 10 vials

12 weeks ≈ 19 vials

16 weeks ≈ 32 vials

Insulin Syringes (U-100):

Per week: 7 syringes (1/day)

8 weeks: 56 syringes

12 weeks: 84 syringes

16 weeks: 112 syringes

Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.

8 weeks (10 vials): 30 mL → 3 × 10 mL bottles

12 weeks (19 vials): 57 mL → 6 × 10 mL bottles

16 weeks (32 vials): 96 mL → 10 × 10 mL bottles

Alcohol Swabs: One for the vial stopper + one for the injection site each day.

Per week: 14 swabs (2/day)

8 weeks: 112 swabs → recommend 2 × 100-count boxes

12 weeks: 168 swabs → recommend 2 × 100-count boxes

16 weeks: 224 swabs → recommend 3 × 100-count boxes